Latest news


PCIB – preliminary results of the rights issue

Posted on Jan 6, 2017

Oslo, January 6, 2017 – Reference is made to the previous announcements by PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) in respect of the fully underwritten rights issue of 10,000,000 new shares in the Company (the “Rights Issue”). The subscription period for the Rights Issue expired at 16:30 CET on 5 January 2017. A […]

PCI Biotech to present at Biotech Showcase 2017

Posted on Jan 6, 2017

Oslo, Norway, January 6, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at the 9th Annual Biotech Showcase™ 2017 being held January 9-11, 2017 at the Hilton San Francisco Union Square, California, US. Taking place during one of the industry’s largest […]

Mandatory notification regarding exercise and trade of subscription rights and trade of shares

Posted on Dec 21, 2016

Oslo, December 21, 2016 – Overview of mandatory notification regarding exercise and trade of subscription rights and trade of shares. Management and the board of directors of PCI Biotech Holding ASA (“PCI Biotech” or “the Company”) are all supportive to the share issue resolved by the extra ordinary general meeting 8 December 2016. In total […]